Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

The Australia molecular diagnostics market was valued at USD 10.32 Billion in 2025 and is expected to grow at a CAGR of 7.90%, reaching USD 22.07 Billion by 2035. The market growth benefits from established healthcare infrastructure, increasing adoption of precision medicine, and rising demand for rapid and accurate testing. The expanding use of genomic technologies, point-of-care platforms, and molecular testing in oncology and infectious diseases is expected to support market expansion throughout the forecast period.

Key Market Trends and Insights

  • By product, reagents and kits held 65% market share in the historical period.
  • Based on technology, PCR accounted for 62% of the market in the historical period.
  • By application, infectious disease led the market in the historical period.

Market Size and Forecast

  • Market Size (2025): USD 10.32 Billion
  • Projected Market Size (2035): USD 22.07 Billion
  • CAGR (2026-2035): 7.90%

Compound Annual Growth Rate

7.9%

Value in USD Billion

2026-2035


Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Australia Molecular Diagnostics Market Overview

Molecular diagnostics supports modern healthcare by enabling the detection of genetic, infectious, and disease-related biomarkers with high accuracy. Its applications across disease diagnosis, treatment selection, and monitoring continue to strengthen its relevance in clinical practice. The market was valued at USD 10.32 Billion in 2025. The market is supported by growing demand for accurate and timely diagnostic testing, increasing adoption of advanced laboratory technologies, and the expanding use of molecular testing across healthcare settings. Market development is also influenced by improvements in diagnostic infrastructure, increasing disease awareness, and the integration of innovative testing technologies.

Australia Molecular Diagnostics Market Growth Analysis and Key Influencers

Analysis Type

Factors

Example

Market Drivers

Rising neurological disease burden is increasing demand for accurate molecular diagnostics for disease characterization, genetic assessment, and treatment planning.

Approximately 4.5 million Australians were living with neurological conditions in 2025, supporting greater demand for advanced diagnostic testing.

Market Restraints

Complex molecular testing requirements and shortages of specialized laboratory expertise can increase costs and restrict adoption across smaller healthcare facilities.

Specialized infrastructure, trained personnel, and technical expertise can create implementation barriers for laboratories with limited resources.

Market Opportunities

Expanding microbiome diagnostics is creating opportunities for molecular testing in gastrointestinal disease assessment and standardized microbiome profiling.

In August 2026, Genetic Analysis placed its GA-map® Dysbiosis Test at Sydney’s Centre for Digestive Diseases.

Australia Molecular Diagnostics Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

Australia Molecular Diagnostics Market Growth Drivers

Rising Neurological Disease Burden Supports Molecular Diagnostic Demand

The growing burden of neurological conditions is increasing the need for accurate and timely molecular diagnostics for disease characterization, genetic assessment, and treatment planning. According to the Australian Institute of Health and Welfare (AIHW), an estimated 4.5 million Australians, representing approximately 16.5% of the population, were living with neurological conditions in 2025. Migraine alone affected approximately 3.9 million people. This substantial disease burden is expected to encourage greater diagnostic evaluation and adoption of advanced testing technologies, supporting market expansion.

Australia Molecular Diagnostics Market Restraints

Complex Testing Requirements and Skilled Workforce Constraints May Limit Market Expansion

The adoption of molecular diagnostics can be constrained by the need for specialized laboratory infrastructure, trained personnel, and technical expertise to perform and interpret complex molecular tests. These requirements can increase operational costs and create implementation challenges, particularly for smaller laboratories and healthcare facilities with limited resources. Variations in laboratory capabilities and access to specialized testing may further slow the consistent adoption of advanced molecular diagnostic technologies, potentially limiting the pace of market expansion.

Australia Molecular Diagnostics Market Opportunities

Expanding Microbiome Diagnostics Creates New Growth Potential

The increasing clinical application of microbiome-based testing creates scope for expanding molecular diagnostic solutions beyond conventional disease detection. Greater understanding of the relationship between gut microbiota and gastrointestinal disorders is supporting the introduction of specialized molecular testing platforms. For instance, in August 2026, Genetic Analysis announced the first Australian placement of its GA-map® Dysbiosis Test at the Centre for Digestive Diseases in Sydney, providing clinicians with standardized microbiome profiling capabilities. Such developments could broaden clinical applications and support future market growth.

Australia Molecular Diagnostics Market Trends

The market is witnessing several trends, including expanded distribution networks, advanced molecular platforms, and greater access to innovative diagnostic technologies.

Expanding Access to Advanced Molecular Diagnostic Technologies Is Likely to Enhance Market Growth

The market is increasingly characterized by partnerships that improve access to advanced molecular diagnostic instruments, reagents, and laboratory technologies. For instance, in June 2024, Abacus dx announced a commercial partnership with Roche to distribute molecular diagnostics hardware and reagents in Australia, including the LightCycler® systems and MagNA Pure platforms. Such collaborations can strengthen technology availability across research and laboratory settings, support broader adoption of advanced testing solutions, and contribute to market growth.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Australia Molecular Diagnostics Market Share

Infectious Diseases Segment Is Positioned to Lead the Market

The market is segmented by application into oncology, pharmacogenomics, infectious diseases, genetic testing, neurological diseases, cardiovascular diseases, microbiology, and others. Among these, infectious diseases is expected to lead, supported by the substantial burden of infectious conditions and continued demand for rapid and accurate pathogen detection. According to the Australian Institute of Health and Welfare (AIHW), more than 557,000 hospitalizations were attributed to infectious diseases in 2024, while COVID-19 accounted for 43,950 DALYs. This persistent disease burden is expected to sustain demand for molecular testing and support segment growth.

Leading Players in the Australia Molecular Diagnostics Market

The key features of the market report include funding and investment analysis, and strategic initiatives by leading players. The major companies in the market are as follows:

CEPHEID INC.

Cepheid Inc. develops molecular diagnostic solutions centered on its GeneXpert® sample-to-answer PCR platform. Its portfolio includes GeneXpert systems with touchscreen interfaces, GeneXpert Infinity, and GeneXpert Xpress, supporting rapid and scalable molecular testing. The company contributes to the market by providing PCR-based platforms designed to expand accessible, automated molecular testing across healthcare settings.

F. Hoffmann-La Roche AG

F. Hoffmann-La Roche AG provides molecular diagnostic technologies, including the cobas® 5800 system for automated, integrated PCR-based nucleic acid testing. The platform combines instrumentation, consumables, reagents, and data management within standardized workflows. Roche participates in the market through its portfolio of automated molecular testing systems supporting laboratory efficiency and scalable diagnostic testing.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. provides molecular testing technologies, including the Applied Biosystems QuantStudio Absolute Q Digital PCR System, assays, kits, reagents, and consumables. Its digital PCR portfolio supports applications such as rare mutation detection, gene expression analysis, and copy number variation. The company contributes to the Australia molecular diagnostics market through advanced PCR-based molecular analysis solutions.

EIKEN CHEMICAL CO., LTD

Eiken Chemical Co., Ltd. develops healthcare technologies and emphasizes research and development, quality, and access to medical solutions. However, the provided information does not identify a specific molecular diagnostic product or Australia-related activity. Therefore, its direct involvement in the market cannot be established from the supplied source alone.

Other key players in the market include ILLUMINA, INC, BioMérieux SA, QIAGEN N.V., and ABBOTT LABORATORIES.

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Australia Molecular Diagnostics Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Product and Services

  • Instruments
  • Reagents & Kits
  • Services & Software

The market is categorized according to the products and services supporting molecular testing workflows. Increasing diagnostic requirements, laboratory modernization, and the integration of molecular testing into healthcare practices are contributing to market development and expanding the utilization of these solutions.

Market Breakup by Test Location

  • Point-of-Care
  • Self-test or Over the Counter
  • Central Laboratories

Test-location segmentation reflects the diverse settings through which molecular diagnostic testing is delivered in Australia. The growing emphasis on timely diagnosis, accessibility, patient convenience, and decentralized healthcare is influencing the adoption and utilization of molecular diagnostic solutions across different testing environments.

Market Breakup by Technology

  • Polymerase Chain Reaction (PCR)
  • In Situ Hybridization
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Chips and Microarrays
  • Mass Spectrometry
  • Sequencing
  • Transcription Mediated Amplification
  • Others

The Australia molecular diagnostics market encompasses various technological approaches used for molecular detection and analysis. Advances in diagnostic capabilities, automation, testing accuracy, and workflow efficiency are supporting technological development and facilitating broader incorporation of molecular diagnostic methods into clinical and laboratory practices.

Market Breakup by Application

  • Oncology
  • Pharmacogenomics
  • Infectious Diseases
    • Hepatitis
    • HIV
    • CT/NG
    • Hospital Acquired Infections (HAI)
    • HPV
    • Tuberculosis
    • Influenza
    • Others
  • Genetic Testing
  • Neurological Diseases
  • Cardiovascular Diseases
  • Microbiology
  • Others

Application-based segmentation reflects the expanding role of molecular diagnostics across healthcare in Australia. Increasing requirements for accurate disease detection, personalized treatment strategies, early diagnosis, and molecular characterization are contributing to the wider application of these technologies across diverse clinical areas.

Market Breakup by End User

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others

The market is segmented according to the healthcare and diagnostic organizations that utilize molecular testing solutions in Australia. Increasing testing volumes, improvements in laboratory infrastructure, and greater integration of molecular diagnostics into healthcare pathways are supporting utilization across end-user settings.

Key Questions Answered in the Australia Molecular Diagnostics Market Report

  • What was the Australia molecular diagnostics market value in 2025?
  • What is the Australia molecular diagnostics market forecast outlook for 2026-2035?
  • What are the major factors aiding the Australia molecular diagnostics market demand?
  • How has the market performed so far, and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints?
  • What are the major molecular diagnostics market trends?
  • Which product and services is expected to dominate the market segment?
  • Which test location is projected to lead the market segment?
  • Which technology is anticipated to drive the market segment?
  • Which application is likely to dominate the market segment?
  • Which end user is expected to dominate the market segment?
  • Who are the key players involved in the Australia molecular diagnostics market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed through a robust mixed-methods research design combining:

  • Primary Research: In-depth interviews with molecular diagnostics stakeholders, including laboratory directors, pathologists, clinical laboratory professionals, diagnostic procurement managers, healthcare providers, and industry experts across Australia, covering major testing and healthcare settings.
  • Secondary Research: Analysis of information from the Australian Government Department of Health and Aged Care, Therapeutic Goods Administration (TGA), Australian Institute of Health and Welfare (AIHW), Australian Bureau of Statistics (ABS), Pathology Australia, peer-reviewed scientific literature, clinical publications, company websites, and relevant industry sources.
  • Validation: Quantitative estimates are triangulated through top-down and bottom-up market modeling, supported by assessment of diagnostic testing volumes, product adoption, pricing trends, healthcare expenditure, and expert feedback. Key company-level information is cross-checked against publicly available corporate and regulatory sources to improve accuracy and consistency.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2025
Historical Period 2019-2025
Forecast Period 2026-2035
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product and Services
  • Test Location
  • Technology
  • Application
  • End User
Breakup by Product and Services
  • Instruments
  • Reagents & Kits
  • Services & Software
Breakup by Test Location
  • Point-of-Care
  • Self-test or Over the Counter
  • Central Laboratories
Breakup by Technology
  • Polymerase Chain Reaction (PCR)
  • In Situ Hybridization
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Chips and Microarrays
  • Mass Spectrometry
  • Sequencing
  • Transcription Mediated Amplification
  • Others
Breakup by Application
  • Oncology
  • Pharmacogenomics
  • Infectious Diseases
  • Genetic Testing
  • Neurological Diseases
  • Cardiovascular Diseases
  • Microbiology
  • Others
Breakup by End User
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • PESTEL Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Company News and Developments
    • Certifications
Companies Covered
  • CEPHEID INC.
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific Inc.
  • EIKEN CHEMICAL CO., LTD
  • ILLUMINA, INC
  • BioMérieux SA
  • QIAGEN N.V.
  • ABBOTT LABORATORIES

Datasheet

10 % Off

USD

1,999

1,799

Single User License

10 % Off

USD

3,099

2,789

Five User License

15 % Off

USD

4,599

3,909

Corporate License

15 % Off

USD

5,999

5,099

Datasheet

One User

USD 1,999

USD 1,799

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 3,099

USD 2,789

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 4,599

USD 3,909

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 5,999

USD 5,099

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us